Search results for "biopharma" in Articles / App Notes

Article Cytiva Advances Fiber Chromatography Technology with New Launch
The launch of HiScreen Fibro PrismA, the company’s newest product for early mAb purification process development strengthens Cytiva’s new fiber-based Protein A platform. On Jan. 27, 2021, Cyti…

Article EMA Guidance on Changes to COVID-19 Vaccines to Fight Variants
The agency is developing guidance to help manufacturers make changes to existing COVID-19 vaccines to treat new variants in the coronavirus. The European Medicines Agency (EMA) has requested t…

Article Cytiva Acquires Vanrx, Innovator in Aseptic Filling
Click here to read more >> Cytiva acquires Vanrx to extend its single-use manufacturing platform with aseptic-filling solutions.

Article Biacore SPR Technology Applied to Precision Diagnostics
Sign up >> Read this overview of Biacore™ surface plasmon resonance (SPR), a diagnostic tool to aid and simplify immunoassay reagent selection and accelerate the development of fit-for-purpose d…

Article Virus-like Particles as Therapeutic Moieties of the Future
In this 44th article in the “Elements of Biopharmaceutical Production” series, the authors review the status of VLPs as therapeutics as well as challenges associated with their analytical and function…

Article Life Science Online Training: Build Your Skills and Continue Your Education
Click here to learn more >> Cytiva continuously adds courses to cover a spectrum of life science topics such as chromatography and bioprocessing. You can find valuable course content for researc…

Article Cytiva and 4Tune Engineering Collaborate on Cell Therapy Quality Risk Management
The collaboration addresses the need for risk mitigation plans in cell therapies. On Dec. 3, 2020, Cytiva and 4Tune Engineering, a manufacturing-sciences and technology company, announced that th…

Article Start-to-Finish Connected Manufacturing
Click here to learn more >> We understand that evaluating new biomanufacturing technologies that promise efficiency gains is challenging. That’s why we are demonstrating our mAb process that te…

Article Akron Bio Will Install a Cytiva FlexFactory to Manufacture Plasmid DNA
Cytiva will provide the first FlexFactory to be used in the manufacture of pDNA to Akron Bio. Cytiva will provide its FlexFactory, a flexible, single-use platform, to enable Akron Biotech to m…

Article Reimagining Affordable Biosimilars
More than 300 active biopharmaceutical product licenses in the market today bear witness to increasing interest in targeted treatments. With an anticipated valuation of over $200 billion by 2022, this…

Show All Results

Previous PageNext Page